Wilmington Savings Fund Society’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
AI
Wilmington Savings Fund Society's CRL Position: Q2 2026 in Review
Wilmington Savings Fund Society increased its Charles River Laboratories (CRL) stake by 0.95% in Q2 2026, buying an estimated $3.03K and bringing the position to 1,807 shares worth $410K. The position accounts for 0.01% of the portfolio, ranked #456.
Wilmington Savings Fund Society first reported a position in CRL in Q3 2024 and has held it in 7 quarters since. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.
- Wilmington Savings Fund Society held 1,807 shares of Charles River Laboratories worth $410K as of Q2 2026.
- Wilmington Savings Fund Society bought 17 Charles River Laboratories shares in Q2 2026, an estimated $3.03K.
- Charles River Laboratories made up 0.01% of Wilmington Savings Fund Society's portfolio in Q2 2026, its #456 holding.
- Wilmington Savings Fund Society first reported a position in Charles River Laboratories in Q3 2024 and has held it in 7 quarters since.
- 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.
Based on Wilmington Savings Fund Society's 13F filing for Q2 2026, filed 28 Jul 2026.